Literature DB >> 19913032

Molecular switch in the glucocorticoid receptor: active and passive antagonist conformations.

Guillaume A Schoch1, Brigitte D'Arcy, Martine Stihle, Dominique Burger, Dominik Bär, Jörg Benz, Ralf Thoma, Armin Ruf.   

Abstract

Mifepristone is known to induce mixed passive antagonist, active antagonist, and agonist effects via the glucocorticoid receptor (GR) pathway. Part of the antagonist effects of mifepristone are due to the repression of gene transcription mediated by the nuclear receptor corepressor (NCoR). Here, we report the crystal structure of a ternary complex of the GR ligand binding domain (GR-LBD) with mifepristone and a receptor-interacting motif of NCoR. The structures of three different conformations of the GR-LBD mifepristone complex show in the oxosteroid hormone receptor family how helix 12 modulates LBD corepressor and coactivator binding. Differences in NCoR binding and in helix 12 conformation reveal how the 11beta substituent in mifepristone triggers the helix 12 molecular switch to reshape the coactivator site into the corepressor site. Two observed conformations exemplify the active antagonist state of GR with NCoR bound. In another conformation, helix 12 completely blocks the coregulator binding site and explains the passive antagonistic effect of mifepristone on GR. Copyright 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19913032     DOI: 10.1016/j.jmb.2009.11.011

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  33 in total

1.  X-ray structures of progesterone receptor ligand binding domain in its agonist state reveal differing mechanisms for mixed profiles of 11β-substituted steroids.

Authors:  Scott J Lusher; Hans C A Raaijmakers; Diep Vu-Pham; Bert Kazemier; Rolien Bosch; Ross McGuire; Rita Azevedo; Hans Hamersma; Koen Dechering; Arthur Oubrie; Marcel van Duin; Jacob de Vlieg
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

2.  Research resource: modulators of glucocorticoid receptor activity identified by a new high-throughput screening assay.

Authors:  John A Blackford; Kyle R Brimacombe; Edward J Dougherty; Madhumita Pradhan; Min Shen; Zhuyin Li; Douglas S Auld; Carson C Chow; Christopher P Austin; S Stoney Simons
Journal:  Mol Endocrinol       Date:  2014-05-21

3.  Synthesis, spectral characterization, and in vitro cellular activities of metapristone, a potential cancer metastatic chemopreventive agent derived from mifepristone (RU486).

Authors:  Jichuang Wang; Jianzhong Chen; Liyuan Wan; Jingwei Shao; Yusheng Lu; Yewei Zhu; Minrui Ou; Suhong Yu; Haijun Chen; Lee Jia
Journal:  AAPS J       Date:  2014-01-18       Impact factor: 4.009

4.  Probing Dominant Negative Behavior of Glucocorticoid Receptor β through a Hybrid Structural and Biochemical Approach.

Authors:  Jungki Min; Lalith Perera; Juno M Krahn; Christine M Jewell; Andrea F Moon; John A Cidlowski; Lars C Pedersen
Journal:  Mol Cell Biol       Date:  2018-03-29       Impact factor: 4.272

5.  Structural Basis for Small Molecule NDB (N-Benzyl-N-(3-(tert-butyl)-4-hydroxyphenyl)-2,6-dichloro-4-(dimethylamino) Benzamide) as a Selective Antagonist of Farnesoid X Receptor α (FXRα) in Stabilizing the Homodimerization of the Receptor.

Authors:  Xing Xu; Xin Xu; Peng Liu; Zhi-yuan Zhu; Jing Chen; Hai-an Fu; Li-li Chen; Li-hong Hu; Xu Shen
Journal:  J Biol Chem       Date:  2015-06-22       Impact factor: 5.157

Review 6.  The glucocorticoid receptor and its expression in the anterior pituitary and the adrenal cortex: a source of variation in hypothalamic-pituitary-adrenal axis function; implications for pituitary and adrenal tumors.

Authors:  George Briassoulis; Svetozar Damjanovic; Paraskevi Xekouki; Hervé Lefebvre; Constantine A Stratakis
Journal:  Endocr Pract       Date:  2011 Nov-Dec       Impact factor: 3.443

7.  GR SUMOylation and formation of an SUMO-SMRT/NCoR1-HDAC3 repressing complex is mandatory for GC-induced IR nGRE-mediated transrepression.

Authors:  Guoqiang Hua; Laetitia Paulen; Pierre Chambon
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-28       Impact factor: 11.205

8.  First High-Resolution Crystal Structures of the Glucocorticoid Receptor Ligand-Binding Domain-Peroxisome Proliferator-Activated γ Coactivator 1-α Complex with Endogenous and Synthetic Glucocorticoids.

Authors:  Xu Liu; Yashuo Wang; Eric A Ortlund
Journal:  Mol Pharmacol       Date:  2019-08-07       Impact factor: 4.436

9.  Evaluation of tetrabromobisphenol A effects on human glucocorticoid and androgen receptors: A comparison of results from human- with yeast-based in vitro assays.

Authors:  Katharina R Beck; Tanja J Sommer; Daniela Schuster; Alex Odermatt
Journal:  Toxicology       Date:  2016-09-28       Impact factor: 4.221

10.  Disruption of a key ligand-H-bond network drives dissociative properties in vamorolone for Duchenne muscular dystrophy treatment.

Authors:  Xu Liu; Yashuo Wang; Jennifer S Gutierrez; Jesse M Damsker; Kanneboyina Nagaraju; Eric P Hoffman; Eric A Ortlund
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.